how does glutathione s-transferase cause drug resistance in cancer cells

how does glutathione s-transferase cause drug resistance in cancer cells Unveiling the Role of Protein Breast Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione S-Transferases in Cancer -

Name: how does glutathione s-transferase cause drug resistance in cancer cells Unveiling the Role of Protein Breast Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione S-Transferases in Cancer -
Brand: vinyldecals4u.com
SKU: 82365844102
Price: 27.14 USD
Availability: InStock
Rating: 4.2763 (18 reviews)

Glutathione S Transferases in Cancer PMC Frontiers Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches Glutathione transferases: substrates, inihibitors and pro drugs in cancer and neurodegenerative diseases Oncogenesis Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect can glutathione cause breast tenderness Unveiling the Role of S transferase Protein in Cancer Drug Resistance: Insights into the Signaling Pathways and Therapeutic Implications Glutathione Injections: Side Effects & Glutathione S transferase : a potential role in antitumor therapy DDDT Dove Medical Press

SKU: 82365844102 · From vinyldecals4u.com

4.3

USD27.14 USD52.14

Pay in 4 interest-free payments of $6.79 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

De la Fuente M, Hernanz A, Guayerbas N (2008) Vitamin E ingestion improves several immune functions in elderly men and women

Arsenic-transformed malignant prostate epithelia can convert noncontiguous normal stem cells into an oncogenic phenotype

Can it be purchased in bulk

demonstrated in patients with advanced colorectal cancer treated by either anti-EGFR inhibition or without, the expression of autophagy proteins Beclin-1 and LC3 were not only associated with advanced colorectal cancer, but those with higher expression of these proteins experienced worse objective response rates, and shorter progression free survival